Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO. Watch the video here.

Less Ads, More Data, More Tools Register for FREE
Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO
Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPOView Video
Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant
Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plantView Video

Latest Share Chat

Transaction with Affiliate Company

31 Jan 2018 07:25

RNS Number : 4394D
Samsung Electronics Co. Ld
31 January 2018
 

Transaction with Affiliate Company

 

Samsung Electronics Co., Ltd. (KS005930, KS005935, SMSN, SMSD) ("SEC") today announced that its Board of Directors has authorized the following related-party transaction with an affiliated company.

 

Trademark License Agreement

- Grant trademark license to Samsung Medicine

Major Transaction Terms

Transaction Item

License fee for use of trademark

Transaction Date

January 31, 2013

Transaction Period

January 31, 2013-January 31, 2018

Transaction Value

KRW 5,604 million (total transaction value: KRW 5,604 million)

Contract Type

Negotiated Contract

Terms and Conditions

* On a cumulative basis, the license fee was below KRW 5 billion at the end of 2016, but exceeded KRW 5 billion after adding the fee for 2017. Accordingly, the payment shall be made upon the approval of the Board of Directors.

* The transaction date is the date when the trade license agreement with Samsung Medicine was made.

* The transaction value is the cumulative amount of the license fee during the transaction period (five years).

* The license fee is set at 0.5% of Samsung Medicine's revenue (not including revenue from licensor or revenue from consignment sales) each year during the transaction period

Other Information:

ž Number of Independent Directors Present at the BOD Meeting: 5

ž Attendance of Audit Committee: Y

 

This disclosure is in accordance with the Korean Fair Trade Act, which mandates that a company must disclose financial and real estate transactions in the event the value of such a transaction is greater or equal to KRW 5 billion and the counterparty is a financial affiliate of the party required to make the disclosure.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCSDDSWFFASEEF

Related Shares

Back to RNS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.